Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Cardiology. Heart & Vasculature|March 7, 2020
Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure RegistryMichele Correale, Adriana Mallardi, Pietro Mazzeo, et al.Clinical Physiology and Functional Imaging|October 5, 2023
Switch to gliflozins and biventricular function improvement in patients with chronic heart failure and diabetes mellitusMichele Correale, Pietro Mazzeo, Martino Fortunato, et al.Acta Cardiologica|August 6, 2021
Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartanMichele Correale, Adriana Mallardi, Lucia Tricarico, et al.International Journal of Cardiology. Heart & Vasculature|April 30, 2020
Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterizationMichele Correale, Ilenia Monaco, Armando Ferraretti, et al.Heart Failure Reviews|August 5, 2019
Delirium in heart failureMichele Correale, Mario Altamura, Raffaella Carnevale, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 20, 2021
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysisPietro Ameri, Vincenzo De Marzo, Giuseppe Biondi Zoccai, et al.Journal of Clinical Medicine|February 11, 2023
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/ValsartanMichele Correale, Michele Magnesa, Pietro Mazzeo, et al.Echocardiography (Mount Kisco, N.Y.)|June 10, 2024
Combined peripheral and central ultrasound for the diagnosis of PAH-SSc patientsMichele Correale, Cinzia Rotondo, Ester Maria Lucia Bevere, et al.Cardiovascular Drugs and Therapy|February 22, 2020
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled StudiesNatale Daniele Brunetti, Lucia Tricarico, Roland R Tilz, et al.Cardiovascular Drugs and Therapy|July 30, 2021
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 PandemicMichele Correale, Francesca Croella, Alessandra Leopizzi, et al.Pageof 6